Aytu BioPharma(NASDAQ:AYTU) stock fell by 8.33% on Tuesday after the company reported its Q4 earnings results on Monday, September 27, 2021 at 04:01 PM.
Here’s what investors need to know about the announcement.
Earnings
Aytu BioPharma missed their estimated earnings by 65.31%, which surprised analysts.
Revenue was up $8,621,000 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $-0.12, which was followed by a 3.21% drop in the share price the next day.
Here’s a look at Aytu BioPharma’s past performance and the resulting price change:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|---|
| EPS Estimate | -0.49 | -0.31 | -0.44 | -0.05 | -0.03 |
| EPS Actual | -0.81 | -0.43 | -0.70 | -0.04 | -0.02 |
| Price Change % | -8.33% | -3.21% | -1.95% | -5.9% | -12.78% |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
